Expanding the use of retinoids in acute myeloid leukemia: spotlight on bexarotene
- PMID: 18765520
- DOI: 10.1158/1078-0432.CCR-08-1081
Expanding the use of retinoids in acute myeloid leukemia: spotlight on bexarotene
Comment on
-
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.Clin Cancer Res. 2008 Sep 1;14(17):5619-25. doi: 10.1158/1078-0432.CCR-07-5185. Clin Cancer Res. 2008. PMID: 18765556 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical